Arrowhead Pharmaceuticals Inc

NASDAQ:ARWRUnited States

Today

Show headlines and story abstract

• DJ Arrowhead Pharmaceuticals Up Over 13%, on Pace for Largest Percent Increase Since November 2022 -- Data Talk, from 50 minutes ago by Dow Jones

  50 minutes ago by Dow Jones
  Companies Mentioned: ARWR
  
  Arrowhead Pharmaceuticals, Inc. (ARWR) is currently at $21.36, up $2.57 or 13.65%
  
  --Would be highest close since Nov. 14, 2024, when it closed at $21.41
  
  --On pace for largest percent increase since Nov. 10, 2022, when it rose 14.02%
  

• Sector Update: Health Care Stocks Advance Tuesday Afternoon, from 1 hour ago by MT Newswires

  1 hour ago by MT Newswires
  Companies Mentioned: LLY, NVO, AMGN, ARWR, SRPT
  01:49 PM EST, 11/26/2024 (MT Newswires) -- Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index adding 0.4% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%. The iShares Biotechnology ETF (IBB) shed 0.3%. In corporate ...

• Sector Update: Health Care, from 1 hour ago by MT Newswires

  1 hour ago by MT Newswires
  Companies Mentioned: ARWR, SRPT
  01:31 PM EST, 11/26/2024 (MT Newswires) -- Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index rising 0.5% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%. The iShares Biotechnology ETF (IBB) shed 0.4%. In corporate ...

• Top Midday Gainers, from 2 hours ago by MT Newswires

  2 hours ago by MT Newswires
  Companies Mentioned: NRG, SMTC, ARWR, SRPT
  01:02 PM EST, 11/26/2024 (MT Newswires) -- Semtech (SMTC) reported late Monday fiscal Q3 earnings and revenue that beat consensus estimates. The chipmaker also issued fiscal Q4 guidance above analyst forecasts. Semtech shares recently were up more t...

• Arrowhead Pharma, Sarepta Therapeutics Sign Licensing, Partnership Deal for Clinical, Preclinical Programs, from 7 hours ago by MT Newswires

  7 hours ago by MT Newswires
  Companies Mentioned: ARWR, SRPT
  08:14 AM EST, 11/26/2024 (MT Newswires) -- Arrowhead Pharmaceuticals (ARWR) and Sarepta Therapeutics (SRPT) have struck a global licensing and partnership deal for clinical and preclinical programs in genetic diseases of the muscle, central nervous ...